ParkinsonCanadaV1, PascalFrancis, Corpus, bibRecord, 000A95

Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model

Identifieur interne : 000A95 ( PascalFrancis/Corpus ); précédent : 000A94; suivant : 000A96

Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model

Auteurs : Pierre J. Blanchet ; Frédéric Calon ; Marc Morissette ; Martin Goulet ; Richard Grondin ; Daniel Levesque ; Paul J. Bedard ; Thérèse Di Paolo

Source :

Advances in neurology [ 0091-3952 ] ; 2001.

RBID : Pascal:03-0237958

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Récepteur dopaminergique, Primates, Traitement, Chimiothérapie, Modèle animal.

English descriptors

KwdEn :
- Animal model, Chemotherapy, Dopamine receptor, Parkinson disease, Primates, Treatment.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0091-3952`
A02	`01`			`@0 ADNRA3`
A03		`1`		`@0 Adv. neurol.`
A05				`@2 86`
A08	`01`	`1`	`ENG`	`@1 Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model`
A09	`01`	`1`	`ENG`	`@1 Parkinson's disease`
A11	`01`	`1`		`@1 BLANCHET (Pierre J.)`
A11	`02`	`1`		`@1 CALON (Frédéric)`
A11	`03`	`1`		`@1 MORISSETTE (Marc)`
A11	`04`	`1`		`@1 GOULET (Martin)`
A11	`05`	`1`		`@1 GRONDIN (Richard)`
A11	`06`	`1`		`@1 LEVESQUE (Daniel)`
A11	`07`	`1`		`@1 BEDARD (Paul J.)`
A11	`08`	`1`		`@1 DI PAOLO (Thérèse)`
A12	`01`	`1`		`@1 CALNE (Donald) @9 ed.`
A12	`02`	`1`		`@1 CALNE (Susan M.) @9 ed.`
A14	`01`			`@1 Neurosciences Research Unit, Hôpital Saint-Luc du CHUM @2 Montreal, Québec H2X 3J4 @3 CAN @Z 1 aut.`
A14	`02`			`@1 Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL @2 Québec G1V 4G2 @3 CAN @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut. @Z 8 aut.`
A14	`03`			`@1 Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL @2 Québec G1V 4G2 @3 CAN @Z 6 aut. @Z 7 aut.`
A15	`01`			`@1 Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon @2 Vancouver, British Columbia @3 CAN @Z 1 aut. @Z 2 aut.`
A18	`01`	`1`		`@1 World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders" @3 INC @9 patr.`
A18	`02`	`1`		`@1 Pacific Parkinsons Research Institute @3 CAN @9 patr.`
A20				`@1 337-344`
A21				`@1 2001`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 15741 @5 354000109446770340`
A44				`@0 0000 @1 © 2003 INIST-CNRS. All rights reserved.`
A45				`@0 35 ref.`
A47	`01`	`1`		`@0 03-0237958`
A60				`@1 P @2 C`
A61				`@0 A`
A64	`01`	`1`		`@0 Advances in neurology`
A66	`01`			`@0 USA`
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Récepteur dopaminergique @5 17`
C03	`02`	`X`	`ENG`	`@0 Dopamine receptor @5 17`
C03	`02`	`X`	`SPA`	`@0 Receptor dopaminérgico @5 17`
C03	`03`	`X`	`FRE`	`@0 Primates @2 NS @5 19`
C03	`03`	`X`	`ENG`	`@0 Primates @2 NS @5 19`
C03	`03`	`X`	`SPA`	`@0 Primates @2 NS @5 19`
C03	`04`	`X`	`FRE`	`@0 Traitement @5 20`
C03	`04`	`X`	`ENG`	`@0 Treatment @5 20`
C03	`04`	`X`	`SPA`	`@0 Tratamiento @5 20`
C03	`05`	`X`	`FRE`	`@0 Chimiothérapie @5 21`
C03	`05`	`X`	`ENG`	`@0 Chemotherapy @5 21`
C03	`05`	`X`	`SPA`	`@0 Quimioterapia @5 21`
C03	`06`	`X`	`FRE`	`@0 Modèle animal @5 22`
C03	`06`	`X`	`ENG`	`@0 Animal model @5 22`
C03	`06`	`X`	`SPA`	`@0 Modelo animal @5 22`
C07	`01`	`X`	`FRE`	`@0 Mammalia @2 NS`
C07	`01`	`X`	`ENG`	`@0 Mammalia @2 NS`
C07	`01`	`X`	`SPA`	`@0 Mammalia @2 NS`
C07	`02`	`X`	`FRE`	`@0 Vertebrata @2 NS`
C07	`02`	`X`	`ENG`	`@0 Vertebrata @2 NS`
C07	`02`	`X`	`SPA`	`@0 Vertebrata @2 NS`
C07	`03`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`03`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`03`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`04`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`05`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`05`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`05`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`06`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`06`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`06`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`07`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`07`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`07`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
N21				`@1 146`
N82				`@1 PSI`

A30	`01`	`1`	`ENG`	`@1 Parkinson's Disease. International Congress @3 Vancouver CAN @4 1999-07-25`

Format Inist (serveur)

NO :	PASCAL 03-0237958 INIST
ET :	Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model
AU :	BLANCHET (Pierre J.); CALON (Frédéric); MORISSETTE (Marc); GOULET (Martin); GRONDIN (Richard); LEVESQUE (Daniel); BEDARD (Paul J.); DI PAOLO (Thérèse); CALNE (Donald); CALNE (Susan M.)
AF :	Neurosciences Research Unit, Hôpital Saint-Luc du CHUM/Montreal, Québec H2X 3J4/Canada (1 aut.); Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL/Québec G1V 4G2/Canada (2 aut., 3 aut., 4 aut., 5 aut., 8 aut.); Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL/Québec G1V 4G2/Canada (6 aut., 7 aut.); Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon/Vancouver, British Columbia/Canada (1 aut., 2 aut.)
DT :	Publication en série; Congrès; Niveau analytique
SO :	Advances in neurology; ISSN 0091-3952; Coden ADNRA3; Etats-Unis; Da. 2001; Vol. 86; Pp. 337-344; Bibl. 35 ref.
LA :	Anglais
CC :	002B17G
FD :	Parkinson maladie; Récepteur dopaminergique; Primates; Traitement; Chimiothérapie; Modèle animal
FG :	Mammalia; Vertebrata; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative
ED :	Parkinson disease; Dopamine receptor; Primates; Treatment; Chemotherapy; Animal model
EG :	Mammalia; Vertebrata; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease
SD :	Parkinson enfermedad; Receptor dopaminérgico; Primates; Tratamiento; Quimioterapia; Modelo animal
LO :	INIST-15741.354000109446770340
ID :	03-0237958

Links to Exploration step

Pascal:03-0237958

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model</title>
<author><name sortKey="Blanchet, Pierre J" sort="Blanchet, Pierre J" uniqKey="Blanchet P" first="Pierre J." last="Blanchet">Pierre J. Blanchet</name>
<affiliation><inist:fA14 i1="01"><s1>Neurosciences Research Unit, Hôpital Saint-Luc du CHUM</s1>
<s2>Montreal, Québec H2X 3J4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Calon, Frederic" sort="Calon, Frederic" uniqKey="Calon F" first="Frédéric" last="Calon">Frédéric Calon</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Morissette, Marc" sort="Morissette, Marc" uniqKey="Morissette M" first="Marc" last="Morissette">Marc Morissette</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Goulet, Martin" sort="Goulet, Martin" uniqKey="Goulet M" first="Martin" last="Goulet">Martin Goulet</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Grondin, Richard" sort="Grondin, Richard" uniqKey="Grondin R" first="Richard" last="Grondin">Richard Grondin</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Levesque, Daniel" sort="Levesque, Daniel" uniqKey="Levesque D" first="Daniel" last="Levesque">Daniel Levesque</name>
<affiliation><inist:fA14 i1="03"><s1>Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bedard, Paul J" sort="Bedard, Paul J" uniqKey="Bedard P" first="Paul J." last="Bedard">Paul J. Bedard</name>
<affiliation><inist:fA14 i1="03"><s1>Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Thérèse" last="Di Paolo">Thérèse Di Paolo</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0237958</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 03-0237958 INIST</idno>
<idno type="RBID">Pascal:03-0237958</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A95</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model</title>
<author><name sortKey="Blanchet, Pierre J" sort="Blanchet, Pierre J" uniqKey="Blanchet P" first="Pierre J." last="Blanchet">Pierre J. Blanchet</name>
<affiliation><inist:fA14 i1="01"><s1>Neurosciences Research Unit, Hôpital Saint-Luc du CHUM</s1>
<s2>Montreal, Québec H2X 3J4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Calon, Frederic" sort="Calon, Frederic" uniqKey="Calon F" first="Frédéric" last="Calon">Frédéric Calon</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Morissette, Marc" sort="Morissette, Marc" uniqKey="Morissette M" first="Marc" last="Morissette">Marc Morissette</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Goulet, Martin" sort="Goulet, Martin" uniqKey="Goulet M" first="Martin" last="Goulet">Martin Goulet</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Grondin, Richard" sort="Grondin, Richard" uniqKey="Grondin R" first="Richard" last="Grondin">Richard Grondin</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Levesque, Daniel" sort="Levesque, Daniel" uniqKey="Levesque D" first="Daniel" last="Levesque">Daniel Levesque</name>
<affiliation><inist:fA14 i1="03"><s1>Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bedard, Paul J" sort="Bedard, Paul J" uniqKey="Bedard P" first="Paul J." last="Bedard">Paul J. Bedard</name>
<affiliation><inist:fA14 i1="03"><s1>Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Thérèse" last="Di Paolo">Thérèse Di Paolo</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
<imprint><date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal model</term>
<term>Chemotherapy</term>
<term>Dopamine receptor</term>
<term>Parkinson disease</term>
<term>Primates</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Récepteur dopaminergique</term>
<term>Primates</term>
<term>Traitement</term>
<term>Chimiothérapie</term>
<term>Modèle animal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0091-3952</s0>
</fA01>
<fA02 i1="01"><s0>ADNRA3</s0>
</fA02>
<fA03 i2="1"><s0>Adv. neurol.</s0>
</fA03>
<fA05><s2>86</s2>
</fA05>
<fA08 i1="01" i2="1" l="ENG"><s1>Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Parkinson's disease</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>BLANCHET (Pierre J.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>CALON (Frédéric)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>MORISSETTE (Marc)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>GOULET (Martin)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>GRONDIN (Richard)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>LEVESQUE (Daniel)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>BEDARD (Paul J.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>DI PAOLO (Thérèse)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>CALNE (Donald)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>CALNE (Susan M.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Neurosciences Research Unit, Hôpital Saint-Luc du CHUM</s1>
<s2>Montreal, Québec H2X 3J4</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL</s1>
<s2>Québec G1V 4G2</s2>
<s3>CAN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA15>
<fA18 i1="01" i2="1"><s1>World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders"</s1>
<s3>INC</s3>
<s9>patr.</s9>
</fA18>
<fA18 i1="02" i2="1"><s1>Pacific Parkinsons Research Institute</s1>
<s3>CAN</s3>
<s9>patr.</s9>
</fA18>
<fA20><s1>337-344</s1>
</fA20>
<fA21><s1>2001</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>15741</s2>
<s5>354000109446770340</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>35 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>03-0237958</s0>
</fA47>
<fA60><s1>P</s1>
<s2>C</s2>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Advances in neurology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Récepteur dopaminergique</s0>
<s5>17</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Dopamine receptor</s0>
<s5>17</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Receptor dopaminérgico</s0>
<s5>17</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Primates</s0>
<s2>NS</s2>
<s5>19</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Primates</s0>
<s2>NS</s2>
<s5>19</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Primates</s0>
<s2>NS</s2>
<s5>19</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Traitement</s0>
<s5>20</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Treatment</s0>
<s5>20</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>20</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>21</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>21</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>21</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Modèle animal</s0>
<s5>22</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Animal model</s0>
<s5>22</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Modelo animal</s0>
<s5>22</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fN21><s1>146</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
<pR><fA30 i1="01" i2="1" l="ENG"><s1>Parkinson's Disease. International Congress</s1>
<s3>Vancouver CAN</s3>
<s4>1999-07-25</s4>
</fA30>
</pR>
</standard>
<server><NO>PASCAL 03-0237958 INIST</NO>
<ET>Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model</ET>
<AU>BLANCHET (Pierre J.); CALON (Frédéric); MORISSETTE (Marc); GOULET (Martin); GRONDIN (Richard); LEVESQUE (Daniel); BEDARD (Paul J.); DI PAOLO (Thérèse); CALNE (Donald); CALNE (Susan M.)</AU>
<AF>Neurosciences Research Unit, Hôpital Saint-Luc du CHUM/Montreal, Québec H2X 3J4/Canada (1 aut.); Unité de Neuroscience, Centre Hospitalier Universitaire de Québec, Pavillon CHUL/Québec G1V 4G2/Canada (2 aut., 3 aut., 4 aut., 5 aut., 8 aut.); Unité d'Endocrinologie Moléculaire, Centre Hospitalier Universitaire de Québec, Pavillon CHUL/Québec G1V 4G2/Canada (6 aut., 7 aut.); Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon/Vancouver, British Columbia/Canada (1 aut., 2 aut.)</AF>
<DT>Publication en série; Congrès; Niveau analytique</DT>
<SO>Advances in neurology; ISSN 0091-3952; Coden ADNRA3; Etats-Unis; Da. 2001; Vol. 86; Pp. 337-344; Bibl. 35 ref.</SO>
<LA>Anglais</LA>
<CC>002B17G</CC>
<FD>Parkinson maladie; Récepteur dopaminergique; Primates; Traitement; Chimiothérapie; Modèle animal</FD>
<FG>Mammalia; Vertebrata; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Parkinson disease; Dopamine receptor; Primates; Treatment; Chemotherapy; Animal model</ED>
<EG>Mammalia; Vertebrata; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease</EG>
<SD>Parkinson enfermedad; Receptor dopaminérgico; Primates; Tratamiento; Quimioterapia; Modelo animal</SD>
<LO>INIST-15741.354000109446770340</LO>
<ID>03-0237958</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A95 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000A95 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:03-0237958
   |texte=   Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model

Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model

Source :

Descripteurs français

English descriptors

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri